Morepen Laboratories Completes First Phase of Manufacturing Capacity Expansion Early
What the filing says
- Installed reactor capacity for API and CDMO increased from 535 KL to 614 KL
- Expansion supports scale-up of commercial CDMO supplies and existing API business
- Marks milestone in building scalable, globally compliant manufacturing platform
Why it's rated notable: The filing reports a completed first phase that raises installed reactor capacity from 535 KL to 614 KL, an increase of about 15%, with no amount or cost stated, which places it at medium.
Original filing
Announcement Under Regulation 30 Of The SEBI (LODR)
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other capex / expansion filings this fortnight
- Capex / expansionTinna Rubber & Infrastructure LtdTinna Rubber reports record H1 FY27 profit with 50% EBITDA growth YoY
- Capex / expansionPitti Engg.Pitti Engineering approves ₹450 crore capex for capacity expansion and consolidation
- Capex / expansionPitti Engg.Pitti Engineering reports Q2 & H1 FY27 results, announces ₹450 crore capex for expansion
- Capex / expansionNuvoco VistasNuvoco Vistas reports Q2 FY27 results with 13.5% revenue growth and capacity expansion
- Capex / expansionHindustan Petroleum Corporation LtdHindustan Petroleum Corporation Limited reports Q2 and H1 FY27 financial results
- PC Jeweller reports Q2FY27 results with 28% revenue growth and debt-free status
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.